WeVote
Log In

Bill

Bill

SB 26

HEALTH SERVICES: Provides relative to opioid treatment programs. (gov sig)

2026 Regular Session Introduced by Patrick McMath

Louisiana bill modifying opioid treatment program regulations to adjust licensing, operations, or medication protocols for substance use disorder care facilities.

Effective date 5/15/2026.
0
WeVote Research Nonpartisan
Bill Summary · SB 26

Legislative bill overview

SB 26 modifies Louisiana's regulatory framework for opioid treatment programs (OTPs), which provide medication-assisted treatment for opioid use disorder. The bill adjusts licensing requirements, operational standards, or treatment protocols for these facilities, though specific provisions are not detailed in the available information.

Why is this important

Opioid use disorder remains a significant public health crisis, and treatment program accessibility directly affects overdose prevention and recovery outcomes. Louisiana's OTP regulations influence how many patients can access evidence-based medication like methadone and buprenorphine, making this bill relevant to both healthcare access and community safety.

Potential points of contention

  • Program expansion vs. local concerns: Provisions easing OTP licensing or operations may conflict with community opposition to treatment facilities in certain neighborhoods
  • Treatment capacity and quality balance: Regulatory changes aimed at expanding access could create tensions around maintaining quality standards and adequate staffing
  • Medication access policies: Any modifications to prescribing protocols or medication types offered may face disagreement between harm reduction advocates and those prioritizing abstinence-based approaches

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.